Metastatic colorectal cancer: recent advances in its clinical management - PubMed (original) (raw)
Review
. 2009 Dec;9(12):1829-47.
doi: 10.1586/era.09.143.
Affiliations
- PMID: 19954294
- DOI: 10.1586/era.09.143
Review
Metastatic colorectal cancer: recent advances in its clinical management
Mario E Barugel et al. Expert Rev Anticancer Ther. 2009 Dec.
Abstract
Colorectal cancer (CRC) is frequently complicated by metastatic disease, with the liver being the most common site of metastasis. Surgical resection is the only realistic cure for colorectal liver metastases; however only 10-25% of cases are initially resectable. The introduction of combination chemotherapy has improved survival rates by enabling 10-20% cases with previously unresectable hepatic metastases to become amenable to surgery. Recent results with the biologic agent bevacizumab, a chimeric human-mouse monoclonal antibody against VEGF, and cetuximab, a chimeric human-mouse monoclonal antibody against EGF receptor, have shown that they improve clinical surgical outcomes when added to current first-line regimens in patients with metastatic colorectal cancer. Dual biologic therapy in combination with chemotherapy has, however, yielded disappointing results. Identification of biological markers is expected to help determine which patients are most likely to respond to these newer agents and thus improve targeted therapy.
Similar articles
- Updated options for liver-limited metastatic colorectal cancer.
Alberts SR. Alberts SR. Clin Colorectal Cancer. 2008 Dec;7 Suppl 2:S58-62. doi: 10.3816/CCC.2008.s.009. Clin Colorectal Cancer. 2008. PMID: 19064408 Review. - Chemotherapy for colorectal cancer liver metastases.
Alberts SR, Wagman LD. Alberts SR, et al. Oncologist. 2008 Oct;13(10):1063-73. doi: 10.1634/theoncologist.2008-0142. Epub 2008 Oct 6. Oncologist. 2008. PMID: 18838438 Review. - An update on treatment advances for the first-line therapy of metastatic colorectal cancer.
Lee JJ, Chu E. Lee JJ, et al. Cancer J. 2007 Sep-Oct;13(5):276-81. doi: 10.1097/PPO.0b013e3181570062. Cancer J. 2007. PMID: 17921724 Review. - Treatment options for liver metastases from colorectal cancer.
Lise M, Pilati P, Da Pian P, Mocellin S, Nitti D, Corazzino S. Lise M, et al. J Exp Clin Cancer Res. 2003 Dec;22(4 Suppl):149-56. J Exp Clin Cancer Res. 2003. PMID: 16767922 Review. - Urgent need for a new staging system in advanced colorectal cancer.
Poston GJ, Figueras J, Giuliante F, Nuzzo G, Sobrero AF, Gigot JF, Nordlinger B, Adam R, Gruenberger T, Choti MA, Bilchik AJ, Van Cutsem EJ, Chiang JM, D'Angelica MI. Poston GJ, et al. J Clin Oncol. 2008 Oct 10;26(29):4828-33. doi: 10.1200/JCO.2008.17.6453. Epub 2008 Aug 18. J Clin Oncol. 2008. PMID: 18711170
Cited by
- GLDC promotes colorectal cancer metastasis through epithelial-mesenchymal transition mediated by Hippo signaling pathway.
Yu H, Hu X, Zhang Y, Wang J, Ni Z, Wang Y, Zhu H. Yu H, et al. Med Oncol. 2023 Sep 5;40(10):293. doi: 10.1007/s12032-023-02076-9. Med Oncol. 2023. PMID: 37668829 - Cancer Cells Promote Phenotypic Alterations in Hepatocytes at the Edge of Cancer Cell Nests to Facilitate Vessel Co-Option Establishment in Colorectal Cancer Liver Metastases.
Rada M, Tsamchoe M, Kapelanski-Lamoureux A, Hassan N, Bloom J, Petrillo S, Kim DH, Lazaris A, Metrakos P. Rada M, et al. Cancers (Basel). 2022 Mar 4;14(5):1318. doi: 10.3390/cancers14051318. Cancers (Basel). 2022. PMID: 35267627 Free PMC article. - Angiopoietin1 Deficiency in Hepatocytes Affects the Growth of Colorectal Cancer Liver Metastases (CRCLM).
Ibrahim NS, Lazaris A, Rada M, Petrillo SK, Huck L, Hussain S, Ouladan S, Gao ZH, Gregorieff A, Essalmani R, Seidah NG, Metrakos P. Ibrahim NS, et al. Cancers (Basel). 2019 Dec 20;12(1):35. doi: 10.3390/cancers12010035. Cancers (Basel). 2019. PMID: 31877668 Free PMC article. - Hobson's choice two-stage hepatectomy for multiple and bilobar colorectal liver metastases with portal vein embolization: report of two cases.
Yamashita S, Hasegawa K, Takahashi M, Arita J, Sakamoto Y, Aoki T, Sugawara Y, Kokudo N. Yamashita S, et al. Surg Today. 2015 Apr;45(4):511-6. doi: 10.1007/s00595-014-0953-x. Epub 2014 Jun 19. Surg Today. 2015. PMID: 24943807 - Blockade of the renin-angiotensin system inhibits growth of colorectal cancer liver metastases in the regenerating liver.
Koh SL, Ager EI, Costa PL, Malcontenti-Wilson C, Muralidharan V, Christophi C. Koh SL, et al. Clin Exp Metastasis. 2014 Apr;31(4):395-405. doi: 10.1007/s10585-014-9635-8. Epub 2014 Jan 18. Clin Exp Metastasis. 2014. PMID: 24442969
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical